PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
23.20%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
53.97%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
15.81%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
-6.00%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
-0.50%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
0.75%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
36.32%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
17.09%
Similar operating expenses growth to CRWV's 17.97%. Walter Schloss would investigate norms.
29.84%
Total costs growth above 1.5x CRWV's 18.28%. Michael Burry would check for inefficiency.
60.00%
Interest expense growth above 1.5x CRWV's 1.19%. Michael Burry would check for over-leverage.
-4.47%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
15.85%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
-8.58%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
14.74%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
-6.87%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
191.23%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
17.52%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
-4.61%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
2.36%
Tax expense growth 50-75% of CRWV's 3.78%. Bruce Berkowitz would examine efficiency.
22.62%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
-0.47%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
23.81%
Similar EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
24.19%
Similar diluted EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
-1.36%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-1.44%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.